Evaluation of the implementation of evidence-based pediatric asthma exacerbation treatments in a regional consortium of emergency medical Services Agencies.

Objective: Asthma exacerbations are a frequent reason for pediatric emergency medical services (EMS) encounters. The objective of this study was to examine the implementation of evidence-based treatments for pediatric asthma in a regional consortium of EMS agencies.

Methods: This retrospective study applied the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) implementation framework to data from an EMS agency consortium in the Cincinnati, Ohio region. The study analyzed one year before an oral systemic corticosteroid (OCS) option was added to the agencies' protocol, and five years after the protocol change. We constructed logistic regression models for the primary outcome of , defined as the proportion of pediatric asthma patients who received a systemic corticosteroid. We modeled ( measured monthly over time) using time series models.

Results: A total of 713 patients were included, 133 pre- and 580 post-protocol change. In terms of , 3% ( = 4) of eligible patients received a systemic corticosteroid pre-OCS versus 20% ( = 116) post-OCS. Multivariable modeling of revealed the study period, EMS transport time, months since implementation of OCS, and number of bronchodilators administered by EMS as significant covariates for the administration of a systemic corticosteroid. For it took approximately two years to reach maximal administration of systemic corticosteroids.

Conclusions: Indicators of asthma severity and time since the protocol change were significantly associated with EMS administration of systemic corticosteroids to pediatric asthma patients. The two-year time for maximal suggests further work is required to understand how to best implement evidence-based pediatric asthma treatments in EMS.